We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-8.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$22.8B
AUM Growth
-$4.41B
(-16%)
Cap. Flow
-$1.27B
Cap. Flow
% of AUM
-5.6%
Top 10 Holdings %
Top 10 Hldgs %
36.84%
Holding
614
New
135
Increased
158
Reduced
239
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$187M |
| 3 |
Netflix
NFLX
|
+$179M |
| 4 |
Starbucks
SBUX
|
+$114M |
| 5 |
Novartis
NVS
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$208M |
| 3 |
Salesforce
CRM
|
+$171M |
| 4 |
Dollar Tree
DLTR
|
+$171M |
| 5 |
Adobe
ADBE
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.16% |
| 2 | Healthcare | 22.78% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Communication Services | 9.78% |
| 5 | Financials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Valero Energy
VLO
$90.1B
| $340K | ﹤0.01% |
7,485
-173
| -2% | -$12.6K |
|
377
Agilent Technologies
A
$39.1B
| $331K | ﹤0.01% |
4,621
| – | – |
|
|
SILK
378
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $328K | ﹤0.01% |
10,428
+1,195
| +13% | +$47.8K |
|
|
AMRN
379
Amarin Corp
AMRN
$299M
| $320K | ﹤0.01% |
4,000
-250
| -6% | -$83.1K |
|
|
TLRA
380
DELISTED
Telaria, Inc.
TLRA
| $311K | ﹤0.01% |
51,794
-386,976
| -88% | -$3.84M |
|
381
Levi Strauss
LEVI
$9.44B
| $310K | ﹤0.01% |
24,974
-155,172
| -86% | -$2.74M |
|
382
Rocket Pharmaceuticals
RCKT
$340M
| $307K | ﹤0.01% |
22,000
-4,000
| -15% | -$79.2K |
|
|
HZNP
383
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $296K | ﹤0.01% |
10,000
+7,000
| +233% | +$237K |
|
384
Kohl's
KSS
$2.17B
| $285K | ﹤0.01% |
19,568
-453
| -2% | -$17K |
|
385
Etsy
ETSY
$7.75B
| $279K | ﹤0.01% |
7,246
-7,581
| -51% | -$370K |
|
386
Okta
OKTA
$24.7B
| $276K | ﹤0.01% |
2,260
-3,493
| -61% | -$438K |
|
387
Tetra Tech
TTEK
$8.49B
| $264K | ﹤0.01% |
18,690
-9,265
| -33% | -$158K |
|
388
American Express
AXP
$227B
| $257K | ﹤0.01% |
3,000
-1,400
| -32% | -$163K |
|
389
Workday
WDAY
$39.6B
| $257K | ﹤0.01% |
1,973
-378,831
| -99% | -$63.8M |
|
|
OPTU
390
Optimum Communications Inc
OPTU
$298M
| $250K | ﹤0.01% |
11,231
-1,436,037
| -99% | -$37.5M |
|
391
Dow Inc
DOW
$21.9B
| $240K | ﹤0.01% |
8,215
-188
| -2% | -$7.99K |
|
392
Woodward
WWD
$21.3B
| $240K | ﹤0.01% |
4,037
| – | – |
|
393
Arrowhead Research
ARWR
$11.9B
| $230K | ﹤0.01% |
8,000
-6,000
| -43% | -$242K |
|
394
Inovio Pharmaceuticals
INO
$55.7M
| $223K | ﹤0.01% |
+2,500
| New | +$154K |
|
395
Beyond Air
XAIR
$3.8M
| $200K | ﹤0.01% |
+63
| New | +$164K |
|
396
Fulcrum Therapeutics
FULC
$273M
| $194K | ﹤0.01% |
16,281
-31,500
| -66% | -$504K |
|
397
Citigroup
C
$222B
| $191K | ﹤0.01% |
4,531
-455,410
| -99% | -$30.6M |
|
|
PRNB
398
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $178K | ﹤0.01% |
3,000
-1,000
| -25% | -$58.3K |
|
399
Ocular Therapeutix
OCUL
$1.79B
| $173K | ﹤0.01% |
+35,000
| New | +$173K |
|
400
Kodiak Sciences
KOD
$2.6B
| $167K | ﹤0.01% |
+3,500
| New | +$210K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2020 Portfolio in Review
As of Q1 2020, Fred Alger Management held 614 positions worth $22.8B, down 16% from $27.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Fred Alger Management withdrew a net $1.27B in Q1 2020, closing 65 positions and reducing 239 holdings. Its most notable exit was Dermira, Inc., an estimated $46.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in AtriCure worth $42.4M.
- Fred Alger Management's largest Q1 2020 buy was AtriCure: 1,263,408 shares worth $42.4M.
- Fred Alger Management added most to NVIDIA in Q1 2020, an estimated $190M increase.
- Fred Alger Management's biggest Q1 2020 reduction was Abbott, cutting an estimated $260M.
- Fred Alger Management fully exited Dermira, Inc. in Q1 2020, selling an estimated $46.3M.
- Fred Alger Management's ten largest holdings make up 37% of its $22.8B portfolio in Q1 2020.
- Fred Alger Management opened 135 new positions and closed 65 in Q1 2020.
- Fred Alger Management's portfolio value fell 16% quarter-over-quarter to $22.8B.
Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.